Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on first line management of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Jessicca Lin as the primary speaker and Dr. T. Raja, Dr. Amit Rauthan, Dr. B. K. Smruti and many other panelists who will share the important facts associated with first line management of ALK positive lung cancer.
Starting with the case scenario of non-small cell lung cancer, Dr Jessica has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, the panel discussion will give more knowledge.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.
2.
Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC
3.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
4.
Researchers explore e-bikes for cancer recovery
5.
Men With Prostate Cancer Experience Less Hot Flashes When Using an Affordable Drug.
1.
Unveiling the Hidden Causes of Anemia: A Comprehensive Look at a Common Condition
2.
Immuno-Oncology in Daily Practice: Transforming Cancer Care One Patient at a Time
3.
Organoids & Single-Cell Tools: Breakthroughs in Colorectal Cancer Research
4.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
5.
Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Updates on Standard V/S High Risk Myeloma Treatment
4.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
5.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation